ADIPOQ and breast cancer: Furthermore, in MCF7 human breast cancer cells, adiponectin has been shown to induce anti-proliferative and pro-apoptotic responses by activating the AMPK signaling pathway and inhibiting the MAPK signaling pathways (Dieudonne et al., 2006).